A federal appeals court in New Orleans hears arguments Wednesday on whether a drug used in the most common method of abortion was properly approved by a government agency more than two decades ago.
Arguing for the Biden administration, Sarah Harrington told the judges that the doctors and groups who brought the lawsuit did not have a right to sue because they won’t have to treat people who have taken mifepristone. All three judges seemed skeptical of that argument.
Harrington disputed that, saying that mifepristone is extremely safe, rarely results in complications, and that doctors could cite their conscience and refuse to participate in procedures.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Abortion pill case moves to appeals court, on track for Supreme CourtA federal appeals court in New Orleans hears arguments Wednesday on whether a drug used in the most common method of abortion was properly approved by a government agency more than two decades ago
続きを読む »
Abortion pill case moves to appeals court, on track for Supreme CourtA federal appeals court in New Orleans hears arguments Wednesday on whether a drug used in the most common method of abortion was properly approved by a government agency more than two decades ago.
続きを読む »
Abortion pill case moves to appeals court, on track for Supreme CourtAt issue are the FDA’s initial approval of mifepristone in 2000, and FDA actions making the drug more accessible in later years.
続きを読む »
Mifepristone abortion pill case moves to appeals court, on track for Supreme CourtA federal appeals court in New Orleans hears arguments Wednesday on whether a drug used in the most common method of abortion was properly approved by the FDA in 2000.
続きを読む »
Abortion pill case moves to appeals court, on track for Supreme CourtAt issue are the FDA’s initial approval of mifepristone in 2000, and FDA actions making the drug more accessible in later years.
続きを読む »
Abortion pill case moves to appeals court, on track for Supreme CourtLegal arguments over women’s access to a drug used in the most common method of abortion move to a federal appeals court in New Orleans on Wednesday, in a case challenging a Food and Drug Administration decision made more than two decades ago
続きを読む »